Know your territory. Surgeon data sized to the states you work, built for independent reps and distributors.
Home Markets Company Account © 2026 MedaRep LLC. Built on CMS Medicare utilisation, Open Payments, PECOS Doctors & Clinicians, NPPES and Census data; not endorsed by CMS.
Internal targeting material; not for use in customer-facing claims.
Rank Markets PricingMarkets › CompareCompare two markets Any covered state and procedure, side by side
Debridement & negative-pressure wound therapy
Radiofrequency ablation (facet, genicular, basivertebral) Spinal cord & DRG stimulation Peripheral nerve stimulation & intrathecal pumps
LAA occlusion & loop recorders EP ablation Pacemaker, ICD & CRT implantation
Coronary intervention (PCI) Structural heart (TAVR, TEER) Mechanical circulatory support PFO & septal closure
Superficial venous ablation Aortic endografts (EVAR/TEVAR) Dialysis access Peripheral arterial intervention Carotid revascularization Thrombectomy, IVC filters & venous stents
DBS & VNS Stroke thrombectomy CSF shunts Aneurysm & intracranial embolization
Cholecystectomy & appendectomy Colorectal resection Breast reconstruction Antireflux & hiatal hernia surgery Bariatric surgery Hernia repair
Prostatectomy & nephrectomy Incontinence, prolapse & sacral neuromodulation Hysterectomy, hysteroscopy & ablation BPH procedures Kidney stone management
Cochlear implants Sinus surgery & balloon dilation Ear tubes & middle ear surgery Sleep apnea & airway implants
Cataract & MIGS Vitreoretinal surgery
Bronchoscopy & lung nodule Colonoscopy & upper endoscopy ERCP & endoscopic ultrasound
Tumor ablation Breast biopsy & localization Tumor & fibroid embolization
CGM & insulin pump management
Prostatectomy & nephrectomy · Maryland Prostatectomy & nephrectomy · Texas Surgeons, 2024 15 41 Medicare fee-for-service cases 785 2,404 Growth since 2019 (Medicare FFS) −2.3%/yr −0.5%/yr Forecast cases (Medicare FFS) 910 in 2030 3,280 in 2030 Forecast growth +2.5%/yr to 2030 +5.3%/yr to 2030 Per 1,000 Medicare beneficiaries 0.9 1.2 Medicare Advantage share 28% 59% Out of hospital 0% (+0 pts since 2019) 0% (+0 pts since 2019) Cases per surgeon 52 59 Top 10 surgeons' share 82% 49% Surgeons growing 4 2 New since the base year 2 1 Likely to stop billing it 3 by 2026 12 by 2026 Forecast miss, 1 year (procedure) 5% 5% Company payments per surgeon adding up…
Medicare figures: from CMS; growth and the forecast count fee-for-service alone, which falls as patients move to Medicare Advantage, and the all-Medicare and all-payer estimates come with a paid plan . Out of hospital: surgeons’ claims in surgery centers and offices in CMS’s latest claim summary. Payments: consulting, speaking, meals and travel tied to the procedure’s products in the latest Open Payments year, royalties left out. Both rankings, surgeon by surgeon The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.
Company payments per surgeon $7,747 $16K